5-HT2C receptor modulators: a patent survey.

@article{Lee20105HT2CRM,
  title={5-HT2C receptor modulators: a patent survey.},
  author={Junwon Lee and Myung Eun Jung and Jinhwa Lee},
  journal={Expert opinion on therapeutic patents},
  year={2010},
  volume={20 11},
  pages={1429-55}
}
IMPORTANCE OF THE FIELD The 5-HT(2C) receptor is a GPCR and is one of the 14 subtypes that constitute the serotonin receptor family. The 5-HT₂(C) receptor is exclusively expressed in the CNS where it demonstrates a wide distribution and displays high-affinity interactions with a wide variety of psychiatric medications. Modulators of 5-HT₂(C) have been implicated as a potential treatment for diseases of significant unmet medical need, including obesity, schizophrenia, depression, anxiety… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 133 references

Changes in glucose tolerance and cardiovascular risk factors after 52 weeks of treatment with lorcaserin

  • Scientific Sessions
  • American Diabetes Association,
  • 2010
1 Excerpt

Lorcaserin, a selecetive 5-HT2C agonist, is efficacious for weight loss across patient subgroups. American Diabetes

  • Scientific Sessions
  • 2010

a patent survey 1450 Expert Opin

  • G Griebel, G Perrault, Sanger DJ. A comparative study of the effects of selective, non-selective 5-HT2 receptor subtype antagonists in rat, 5-HT2C receptor modulators
  • Ther. Patents
  • 2010
1 Excerpt

synthesis and biological evaluation

  • D Hammprecht, F Micheli, G Tedesco, derivatives et al. Isoindolone, antagonists a new class of 5-HT2C
  • Bioorg Med Chem Lett 2007;17:428-33 5-HT2C…
  • 2010

Condensed pyridine derivative and use thereof

  • Takeda Pharmaceutical Co. Ltd
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…